SITAGLIPTIN TRIAZECINE ANALOG
UNII 6EV5E35ZMR

Substance Identification & Data

This profile provides standardized clinical and technical data for Sitagliptin Triazecine Analog, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6EV5E35ZMR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2088771-61-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6EV5E35ZMR

CAS Registry Number

2088771-61-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SITAGLIPTIN TRIAZECINE ANALOG

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C16H13F6N5O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

CJUCSNDPMOGZTM-MRVPVSSYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

125270268

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(c(cc(c(c1)C[C@@H]2CC(NCCn3c(C(N2)=O)nnc3C(F)(F)F)=O)F)F)F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sitagliptin Triazecine Analog. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.